We use diversified internal and external discovery platforms to develop antibody in combination with target characteristics and the needs of bi (multi)-specific antibody design.
Fully human phage library
We have obtained a number of monoclonal antibodies or bispecific antibodies screened from the fully human phage library that have entered or are going to enter the clinical stage.
Mouse antibody humanization
For some complex targets such as GPCR or targets requiring special functions, mouse hybridoma technology is used to ensure the diversity of candidates, and the final candidates are obtained through humanization technology.
Alpaca single domain antibody
It is suitable for screening more stable and high-yielding single domain antibodies. VHHs are smaller and more stable than conventional antibodies, yet they possess fully functional antigen-binding capacity. VHH can reach, recognize and bind novel epitopes that regular size antibodies cannot.